JAGX - Jaguar Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4,416.1454,361.186141.523390.953
Cost of Revenue7,920.4945,149.867,258.83174.949
Gross Profit-3,504.349-788.674-7,117.307216.004
Operating Expenses
Research Development---1,672.472
Selling General and Administrative22,108.79810,777.1366,363.2532,618.066
Non Recurring----
Others----
Total Operating Expenses30,029.29215,926.99613,622.0834,465.487
Operating Income or Loss-25,613.147-11,565.81-13,480.56-4,074.534
Income from Continuing Operations
Total Other Income/Expenses Net-6,532.91-23,584.046-1,253.228,977.545
Earnings Before Interest and Taxes-25,613.147-11,565.81-13,480.56-4,074.534
Interest Expense-2,628.685-1,209.632-985.549-8,048.674
Income Before Tax-32,146.057-35,149.856-14,733.784,903.011
Income Tax Expense--13,181.242--
Minority Interest----
Net Income From Continuing Ops-32,146.057-21,968.614-14,733.784,903.011
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-32,146.057-21,968.614-14,733.785,309.161
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-32,146.057-21,968.614-14,733.785,309.161